179 related articles for article (PubMed ID: 12765986)
1. Detection of recombinant human erythropoietin in urine by isoelectric focusing.
Breidbach A; Catlin DH; Green GA; Tregub I; Truong H; Gorzek J
Clin Chem; 2003 Jun; 49(6 Pt 1):901-7. PubMed ID: 12765986
[TBL] [Abstract][Full Text] [Related]
2. Detection of the administration of human erythropoietin (HuEPO) to canines.
Bartlett C; Clancy GJ; Cowan DA; Healy JF
J Anal Toxicol; 2006; 30(9):663-9. PubMed ID: 17137526
[TBL] [Abstract][Full Text] [Related]
3. Detection of recombinant epoetin and darbepoetin alpha after subcutaneous administration in the horse.
Lasne F; Popot MA; Varlet-Marie E; Martin L; Martin JA; Bonnaire Y; Audran M; de Ceaurriz J
J Anal Toxicol; 2005; 29(8):835-7. PubMed ID: 16374944
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
[TBL] [Abstract][Full Text] [Related]
5. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
Dehnes Y; Hemmersbach P
Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
[TBL] [Abstract][Full Text] [Related]
6. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol.
Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M
Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134
[TBL] [Abstract][Full Text] [Related]
7. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
Wilber RL
Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
[TBL] [Abstract][Full Text] [Related]
8. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
Dehnes Y; Shalina A; Myrvold L
Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
[TBL] [Abstract][Full Text] [Related]
9. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
[TBL] [Abstract][Full Text] [Related]
10. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.
Egrie JC; Dwyer E; Browne JK; Hitz A; Lykos MA
Exp Hematol; 2003 Apr; 31(4):290-9. PubMed ID: 12691916
[TBL] [Abstract][Full Text] [Related]
11. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.
Lasne F; Thioulouse J; Martin L; de Ceaurriz J
Electrophoresis; 2007 Jun; 28(12):1875-81. PubMed ID: 17503402
[TBL] [Abstract][Full Text] [Related]
12. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
Voils SA; Harpe SH; Brophy GM
Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
[TBL] [Abstract][Full Text] [Related]
13. Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation.
Morkeberg J; Lundby C; Nissen-Lie G; Nielsen TK; Hemmersbach P; Damsgaard R
Med Sci Sports Exerc; 2007 Oct; 39(10):1742-7. PubMed ID: 17909401
[TBL] [Abstract][Full Text] [Related]
14. Possible indirect detection of rHuEPO administration in human urine by high-performance liquid chromatography tandem mass spectrometry.
Appolonova SA; Dikunets MA; Rodchenkov GM
Eur J Mass Spectrom (Chichester); 2008; 14(3):201-9. PubMed ID: 18708700
[TBL] [Abstract][Full Text] [Related]
15. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
Okano M; Sato M; Kaneko E; Kageyama S
Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
[TBL] [Abstract][Full Text] [Related]
16. Screen and confirmation of PEG-epoetin β in equine plasma.
Chang Y; Maylin GM; Matsumoto G; Neades SM; Catlin DH
Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
[TBL] [Abstract][Full Text] [Related]
17. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
Segura J; Pascual JA; Gutiérrez-Gallego R
Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.
Souillard A; Audran M; Bressolle F; Gareau R; Duvallet A; Chanal JL
Br J Clin Pharmacol; 1996 Sep; 42(3):355-64. PubMed ID: 8877027
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
